🇺🇸 FDA
Patent

US 7875637

Benzimidazole derivative and use as a II receptor antagonist

granted A61PA61P13/12A61P25/00

Quick answer

US patent 7875637 (Benzimidazole derivative and use as a II receptor antagonist) held by Takeda Pharmaceutical Company Limited expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P13/12, A61P25/00, A61P25/28, A61P3/00